SCHEMBL8439610

SCHEMBL8439610

CN(C)Cc1cc2c(o1)CCN(C(=O)c1ccc(/C=C\c3ccc(Cl)cc3)cc1)C2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LSS P48449 2/20 0.44
GPR183 P32249 3/20 0.41
POLB P06746 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4D Q08499 1/20 0.40
KCNH2 Q12809 2/20 0.40
QRFPR Q96P65 2/20 0.40
CYP2D6 P10635 1/20 0.40
KCNE1 P15382 1/20 0.40
SCN5A Q14524 1/20 0.40
HSP90AB1 P08238 1/20 0.39
GRM5 P41594 1/20 0.38
SNCA P37840 1/20 0.38
MTHFD1 P11586 1/20 0.38
MTHFD2 P13995 1/20 0.38
ITGB2 P05107 2/20 0.38
ICAM1 P05362 2/20 0.38
ITGAL P20701 2/20 0.38
PHGDH O43175 1/20 0.38
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8439613 1.00 LSS (0.44) LSSGPR183POLBPDE4BPDE4D
Hydrochloric Acid SCHEMBL8440747 0.99 LSS (0.43) LSSGPR183POLBPDE4BPDE4D
Hydrochloric Acid SCHEMBL8440753 0.99 LSS (0.43) LSSGPR183POLBPDE4BPDE4D
SCHEMBL8440702 0.93 SNCA (0.42) LSSGPR183PDE4BPDE4DKCNH2
SCHEMBL8440708 0.93 SNCA (0.42) LSSGPR183PDE4BPDE4DKCNH2
SCHEMBL8434898 0.92 ALDH1A1 (0.41) CYP2D6HSP90AB1GRM5SNCAMTHFD1
SCHEMBL8437896 0.92 LSS (0.44) LSSGPR183POLBPDE4BPDE4D
SCHEMBL8434901 0.92 ALDH1A1 (0.41) CYP2D6HSP90AB1GRM5SNCAMTHFD1
SCHEMBL8437891 0.92 LSS (0.44) LSSGPR183POLBPDE4BPDE4D
SCHEMBL8435004 0.92 ALDH1A1 (0.41) CYP2D6HSP90AB1GRM5SNCAMTHFD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5998433-A THERAPY FOR HYPERLIPIDEMIA; ATHEROSCLEROSIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-12-07 US disclosed
EP-0785939-A1 SUBSTITUTED HETEROBICYCLIC ALKYL AMINES AND THEIR USE AS SQUALENE OXIDE CYCLASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 1997-07-30 EP disclosed
WO-1996011201-A1 SUBSTITUTED HETEROBICYCLIC ALKYL AMINES AND THEIR USE AS SQUALENE OXIDE CYCLASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-04-18 WO disclosed